Robert F Doman's Net Worth
$5.54 Million
Who is Robert F Doman?
Robert F Doman has an estimated net worth of $5.54 Million. This is based on reported shares across multiple companies, which include Celsus Therapeutics Plc., DUSA PHARMACEUTICALS INC, and Echo Therapeutics, Inc..
SEC CIK
Robert F Doman's CIK is 0001313163
Past Insider Trading and Trends
2013 was Robert F Doman's most active year for acquiring shares with 10 total transactions. Robert F Doman's most active month to acquire stocks was the month of February. 2012 was Robert F Doman's most active year for disposing of shares, totalling 13 transactions. Robert F Doman's most active month to dispose stocks was the month of November. 2006 saw Robert F Doman paying a total of $13,320.00 for 52,000 shares, this is the most they've acquired in one year. In 2012 Robert F Doman cashed out on 1,254,493 shares for a total of $5,510,812.21, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Celsus Therapeutics Plc. (AKTX) Snapshot price: $3.69
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DUSA PHARMACEUTICALS INC No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -686.44K |
$8.00 | -$5,491,488.00 |
0
|
Dec 20
| |||
Form 4
| -0.23% | -1.51K |
$6.13 | -$9,231.78 | 666.69K |
May 9
| |||
Form 4
| -1.10% | -7.42K |
$5.86 | -$43,469.48 | 668.19K |
Mar 13
| |||
Form 4
| +42.45% | 307.32K |
$6.05 | -$76,714.00 | 1.03M |
Mar 7 - Mar 8
| |||
Form 4
| -2.72% | -10.30K |
$4.65 | -$47,908.95 | 368.29K |
Mar 5
| |||
Form 4
| -0.38% | -1.51K |
$5.80 | -$8,746.40 | 398.34K |
Jun 9 - May 9
| |||
Form 4
| -1.85% | -7.43K |
$4.15 | -$30,834.50 | 395.1K |
Mar 13
| |||
Form 4
| +30.22% | 149.68K |
$3.95 | -$40,760.05 | 645.06K |
Mar 4 - Mar 7
| |||
Form 4
| +105.82% | 130K |
—
|
—
| 252.85K |
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
| 127.6K |
Dec 16
| |||
Form 4
| +275.29% | 93.6K |
—
|
—
| 127.6K |
Mar 13
| |||
Form 4
| +4.00% | 5K |
$1.73 | $8,650.00 | 130K |
Aug 22
| |||
Form 4
|
∞
| 19K |
—
|
—
| 19K |
May 9
| |||
Form 4
| +100.00% | 5K |
$2.10 | $10,486.00 | 10K |
Nov 13
| |||
Form 4
| +150.00% | 3K |
$2.84 | $8,520.00 | 5K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 4
|
∞
| 2K |
$6.66 | $13,320.00 | 2K |
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Echo Therapeutics, Inc. No price found
EXEC. CHAIRMAN AND INTERIM CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.30% | 400 |
—
|
—
| 4.7K |
Oct 1
| |||
Form 4/A
| +10.26% | 400 |
—
|
—
| 4.3K |
Jul 1
| |||
Form 4
| +1.03% | 400 |
—
|
—
| 39.4K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 9
| |||
Form 4
| +11.43% | 4K |
—
|
—
| 39K |
Apr 9
| |||
Form 4
| +75.00% | 15K |
$0.80 | $11,961.00 | 35K |
Mar 22
| |||
Form 4
|
∞
| 20K |
—
|
—
| 20K |
Mar 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||